Board of Directors

The AAPS Board of Directors is composed primarily of independent directors, selected from the academic, business, health, and high-tech sectors. Collectively, the Directors possess an extraordinary range of expertise that spans the spectrum from nuclear physics to joint ventures and from engineering to tax law. Directors actively participate in determining AAPS’ strategic direction, safeguarding its resources, and monitoring performance vis-à-vis the fulfillment of its mission and objectives.



Dr. Don Brooks, Chairman

Dr. Don Brooks is a Physical Biochemist and Professor in the Departments of Pathology & Laboratory Medicine and Chemistry at UBC. Following a variety of service roles in Pathology he served as UBC’s Associate Vice President Research & International (AVPRI) from 2001 to 2011 and as Founding Director of the SPARC Office 2011-2013. In these positions he played a leadership role in promoting research (federally and provincially) and building research excellence, capacity and competitiveness at U.B.C. His major current research interests are in surface and polymer chemistry, particularly in developing polymer constructs for biomedical applications including blood compatible materials, blood plasma protein substitutes and drug delivery in which his group is widely recognized. While AVPRI, the CFI/BCKDF Resource Office, the Health Research Resource Office reported directly to him. He also worked extensively with the research communities of the UBC teaching hospitals, the BC Cancer Agency and the BC Children’s Hospital on recruitment and cooperative projects. He sat on the Board of the Child & Family Health Research Institute 2002-2011, as Chair 2009-20011. This ultimately resulted in his appointment by the Minister of Health to the Boards of Directors of the Provincial Health Services Authority and the BC Emergency Health Services for 2012-2016; they are responsible for many provincial health programs including the BC Cancer Agency, Children’s and Women’s Hospitals and the BC Ambulance Service.
From April 2014 he was appointed Special Advisor on External Relations, Research to the VP Research and International Office, a position which carries over with it membership on several other Boards with which UBC is involved. These include TRIUMF (ongoing since 2003), AAPS – Advanced Applied Physics Solutions Inc, (Interim Chair of the Board of Directors, 2016), Canadian Light Source – Canada’s national synchrotron facility (2006-2012), PROOF – Prevention of Organ Failure Centre (ongoing since 2008) and ACURA – Association of Canadian Universities for Research in Astronomy.


Dr. Jonathan Bagger

Dr. Jonathan Bagger was elected Director of TRIUMF effective July 1st, 2014. Prior to TRIUMF, he served as Krieger-Eisenhower Professor at Johns Hopkins University, Chair of the Department of Physics and Astronomy, and Vice Provost for Graduate and Postdoctoral Programs. From 2012 to 2013, he served as the university’s Interim Provost and Senior Vice President for Academic Affairs.

Dr. Bagger’s research centers on high-energy physics at the interface of theory and experiment. Together with Julius Wess, he is the author of the monograph Supersymmetry and Supergravity. Dr. Bagger has twice been a member of the Institute for Advanced Study. He served as chair of the International Linear Collider Steering Committee, as vice chair of the U.S. Department of Energy/National Science Foundation High Energy Physics Advisory Panel, and as a member of the U.S. National Research Council’s Board on Physics and Astronomy. He has served on the Fermilab Board of Overseers, the SLAC Scientific Policy Committee, the Space Telescope Institute Council, and the Board of Directors of the National Space Biomedical Research Institute. He is a fellow of the American Physical Society and the American Association for the Advancement of Science.

Dr. Bagger graduated from Dartmouth College in 1977. After a year at Cambridge University as a Churchill Scholar, he continued his graduate studies at Princeton University. He received his Ph.D. in 1983 and took a postdoctoral research position at the Stanford Linear Accelerator Center (SLAC). From 1986 to 1989, he was Associate Professor at Harvard University.


Dr. Pierre Coulombe

Dr. Pierre Coulombe is a seasoned executive and a visionary that played a vital role in the elaboration and implementation of science, technology and innovation policies and in the financing of new economy enterprises. He has more than 30 years of experience in the management of public and private organizations and was a consultant in business strategy and financing. He was President and CEO of Infectio Diagnostic Incorporated, a spin-off biotechnology firm from Laval University Medical School. He was a member of the Board of the Institut National de la Recherche Scientifique (INRS) and the Natural Sciences and Engineering Research Council of Canada (NSERC). In addition, he was also a founding member of the Canadian Biotechnology Advisory Council (CBAC). Over the years, Dr. Coulombe has built an extensive network of collaborators both in Canada and abroad.

Dr. Coulombe was Chairman of the Board and CEO of the Centre de recherche industrielle du Québec, a Government of Quebec Crown Corporation, and former Assistant Deputy Minister (Technology) with the Government of Quebec. He earned Bachelor degrees in arts and physics engineering from Laval University. He also earned a Ph.D. in experimental medicine and was Assistant Professor of Medicine at Laval University. He is a member of the Ordre des ingénieurs du Québec and the CFA (Chartered Financial Analyst) Institute.


Ms. Kathryn Hayashi, President & Chief Executive Officer

Kathryn Hayashi is the President and Chief Executive Officer of AAPS, the commercialization arm of TRIUMF – Canada’s national laboratory for particle and nuclear physics and accelerator-based science.  Prior to AAPS, Ms. Hayashi was the Founding Chief Financial Officer of The Centre for Drug Research and Development (CDRD) and CDRD Ventures Inc, Canada’s national drug development and commercialization engine. As part of the founding team that started CDRD in 2007, she worked to develop a new partnership based model for translating and commercializing Canadian innovation and secure public and private sector funding totaling more than $230M.  At CDRD she worked with a strong business-focused team to complete multiple transactions including the creation of 6 spin out companies (including a significant M&A exit) to establish CDRD as a leader in pre-clinical translational research and commercialization.

Ms. Hayashi also presides as a Director and Audit Committee Chair of the Center for Commercialization and Cancer Immunotherapy at the Hôpital Maisonneuve-Rosemont and has served on the boards of several CDRD spinoff companies.

Ms. Hayashi has over 25 years of industry experience in all areas of operational and strategic planning, finance, and governance, and is a member of the Institute of Chartered Accountants of British Columbia.


Dr. Digvir Jayas

Distinguished Professor Dr. Digvir S. Jayas was educated at the G.B. Pant University of Agriculture and Technology in Pantnagar, India; the University of Manitoba, and the University of Saskatchewan. Before assuming the position of Vice-President (Research and International), he held the position of Vice-President (Research) for two years and Associate Vice-President (Research) for eight years. He is a Registered Professional Engineer and a Registered Professional Agrologist.

Dr. Jayas serves on the boards of many organizations including: NSERC, ArcticNet, Composite Innovation Centre, Engineers Canada, Centre for Innovative Sensing of Structures (SIMTReC), Genome Prairie, MabNet, Manitoba Centre for Health Policy, National Coordinating Centre for Infectious Diseases (NCCID), Research Manitoba, Cancer Care Manitoba Projects Grants and Awards Committee, Research Institute of Oncology and Hematology, TRIUMF, and TRTech. He is also chair of the board of directors of RESOLVE and of the advisory committee of the Richardson Centre for Functional Foods and Nutraceuticals. He has served as President of Agriculture Institute of Canada, Association of Professional Engineers and Geoscientists of Manitoba, Canadian Institute of Food Science and Technology, Canadian Society for Bioengineering, and Manitoba Institute of Agrologists. Currently he is serving as President of Engineers Canada, the national organization of the 12 provincial and territorial associations that regulate the practice of engineering in Canada and license the country’s 280,000 professional engineers.


Dr. Colin H.W. Jones

Dr. Colin H.W. Jones is an accomplished researcher with extensive management and board level experience. Dr. Jones earned his Ph.D. in Radiochemistry from the University of Manchester in 1965. Since that time Dr. Jones has conducted research and written 72 publications in the fields of radiochemistry, Mossbauer spectroscopy and physical inorganic chemistry. Dr. Jones is currently a Professor Emeritus at Simon Fraser University (SFU), where he taught courses in nuclear and radiochemistry and in general chemistry for over 40 years. Dr. Jones has served in numerous management positions at SFU, including Chair of the Department of Chemistry (1979-88), Dean of the Fa

culty of Science (1988-99), Executive Director for International Relations (1999-2002), and Assistant VP Research (2005-07). He is also familiar with TRIUMF, having served on the TRIUMF Board of Management as a Member (1989-2006) and as Chair (1995-2000). He has also served on the Board of Science World and the Science Council of BC.


Dr. Sylvain Lévesque

Since 2010, Dr. Sylvain Lévesque leads strategy at Bombardier Inc. as Vice President, Corporate Strategy. In this role, he heads the strategic planning process, evaluates the value creation potential of each business in Bombardier’s portfolio and develops the strategy for capital allocation and evolution of the portfolio. In 2005, Dr. Lévesque was named Vice President, Finance, Marketing, Contracts and Administration for Bombardier Flexjet. At Flexjet, his mandate was to create strategies to accelerate growth and realize the full potential of Bombardier’s fractional jet ownership program. He designed and launched several new innovative business jet services, which contributed strongly to Flexjet’s 20% annual order growth during his tenure.

He is a graduate of the University of Sherbrooke with a bachelor’s degree in Mechanical and Aeronautical Engineering, and earned a master’s degree and Ph.D. in Mechanical Engineering from the Massachusetts Institute of Technology. Dr.Lévesque is also a board member of TRIUMF, Canada’s national laboratory for particle and nuclear physics and accelerator-based science.


Founding Directors

Edward Odishaw – Chair
Geoffrey Ballard
Michael C. Burns
Poul Hansen
Howard Kellough
Donald Rix
Arthur Willms
Nigel Lockyer
Philip L. Gardner